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Results: Significant differences were found between depressed 
patients and healthy subjects in gray matter volumes in the 
left and right anterior cingulate cortex, left and right middle 
frontal cortex, right dorsolateral frontal cortex, left insula, and 
left and right temporal poles. Gray matter volumes in each of 
these regions, with the exception of the left middle frontal cor-
tex and insula, were significantly smaller in depressed patients 
with bipolar disorder than those with major depressive disor-
der. A support vector machine model incorporating age, sex, and 
gray matter volumes in each brain region distinguished patients 
from healthy subjects with 69.9% accuracy and classified bipolar 
and major depressive disorder patients with 82.9% accuracy.
Conclusions: Reduced gray matter volume in limbic and par-
alimbic structures is a shared pathophysiological feature of 
bipolar disorder and major depressive disorder, whereas severe 
abnormalities allow differentiation between the two disorders. 
Our findings identify morphometric biomarkers of two neu-
ropsychiatric disorders that may allow imaging-aided differen-
tial diagnosis.
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Abstract
Normal subjects with bipolarity phenotype, even though not 
diagnosed bipolar disorder, are known to show distinct prop-
erties. In this study, we investigate the changes in molecu-
lar circadian rhythm after bright light exposure before sleep 
in normal subjects with bipolarity phenotype. 25 young male 
subjects were divided to 14 for bipolarity group and 11 for non-
bipolarity group after scoring of the mood disorder question-
naire (MDQ). During the first two study days, the subjects were 
exposed to the normal-living light (150 lux) for 2.5 hours before 
sleep, and the saliva and buccal cells of subjects were collected 
for a total six regular times periodically. During the subsequent 
five days, the subjects were exposed to the bright light (1,000 
lux), and the saliva and buccal cells were collected in the same 
way. The molecular circadian rhythm of cortisol and circadian 
gene expression ratio (Per1/Bmal1) were analyzed with cosinor 
regression. Circadian rhythm of cortisol showed a delay of acro-
phase in both groups after bright light exposure (p<0.001), and 
bipolarity group showed a significant delay than non-bipolar 
group (p=0.008). Circadian rhythm of circadian gene expression 
ratio showed a delay of acrophase (p<0.001) and a decrease of 
amplitude (p<0.001) after bright light exposure in both groups, 
but there was no group difference. Bipolarity group showed 
hypersensitivity in cortisol rhythm than non-bipolarity group 
after bright light exposure, but not in circadian gene expression. 
These results suggest that the characteristic molecular circa-
dian rhythm change of bipolarity group may be related to the 
biological process after circadian gene expression.
Keywords: bipolarity, circadian rhythm, cortisol, circadian gene, 
light exposure
PS48
Genome-wide association study of psychotic  
subtype in bipolar I disorder
Chau-Shoun Lee, M.D., Ph.D.1; Jung Chen Chang, Ph.D.2; Lawrence 
Shih-Hsin Wu3 Ph.D.; Andrew Tai-Ann Cheng, M.D., Ph.D. 4 M.D., 
Ph.D.3
1Associate Professor, Department of Medicine, MacKay Medical 
College, New Taipei City, Taiwan; Senior Attending Physician, 
Department of Psychiatry, MacKay Memorial Hospital, Taipei, Taiwan 
2Assistant Professor, School of Nursing, College of Medicine, National 
Taiwan University, Taipei, Taiwan 3Institute of Medical Sciences, Tzu 
Chi University, Hualien, Taiwan 4Distinguished Researcher, Institute of 
Biomedical Sciences, Academia Sinica, Taipei, Taiwan
Abstract
Bipolar disorder (BP) is a severe and highly heritable neuropsy-
chiatric disorder. Despite robust evidence of high heritability 
(over 80%), the search for genetic basis of BP has not led to a 
clear insight into its pathogenesis. Clinical phenotype refine-
ment encompasses an approach to identify promising sub-phe-
notypic variables most suitable for genetic studies.
The Taiwan Bipolar Consortium has recruited 1800 unrelated 
bipolar I patients (BPI) up to November 2014 with a Han origin. 
Four genes (SP8, ST8SIA2, CACNB2 and KCTD12) were identified 
via GWAS with 1000 BPI cases and 1000 controls. We have pro-
posed both ion-channelopathy and neurodevelopmental defects 
as the pathological mechanisms for the development of BPI.
In this study, we aim to conduct molecular genetic stud-
ies to identify genes for subphenotypes of psychotic features 
(i.e., delusions and hallucinations) in BP1. We have recruit BP1 
patients to make a total of 2000. Phenotype assessment for delu-
sions and hallucinations have been carried out via standardized 
psychiatric interview using the Chinese version of the WHO 
SCAN (Schedules for Clinical Assessment in Neuropsychiatry) 
plus interview with in-charge psychiatrists and chart review. We 
have conducted GWAS to identify genetic determinants of audi-
tory hallucinations first in a discovery group, then validated in 
a replication group.
Findings of the joint analysis with the best statistical model 
for SNP have found 2 SNPs show the robust statistical evidence 
for association.
We expect to perform high throughput deep sequencing 
using the next generation sequencing platform on regions 
determined by GWAS to identify functional variants and to per-
form functional studies on these variants.
PS49
Shifted Circadian Phase in Manic Episode was 
Returned to Normal after Treatment in Bipolar 
Disorder
Joung-Ho Moon1,2†, Chul-Hyun Cho1†, Gi Hoon Son3, Dongho Geum4, 
Sooyoung Chung5, Hyun Kim6, Seung-Gul Kang7, Young-Min Park8, 
Ho-Kyoung Yoon1, Leen Kim1, Hee-Jung Jee9, Hyonggin An9, Daniel 
F. Kripke10,11, Heon-Jeong Lee 1,2*
1Dept. of Psychiatry, Korea Univ. College of Medicine, Seoul, South 
Korea; 2Dept. of Biomedical Sciences, Korea Univ., Seoul, South 
Korea; 3Dept. of Legal Medicine, Korea Univ. College of Medicine, 
D
ow
nloaded from
 https://academ
ic.oup.com
/ijnp/article-abstract/19/Suppl_1/16/2946385 by guest on 13 M
ay 2020
Abstracts | 17
South Korea; 4Graduate School of Medicine, Korea Univ., Seoul, 
South Korea; 5Dept. of Brain and Cognitive Science, Ewha Woman 
Univ., Seoul, South Korea; 6Dept. of Anatomy, Korea Univ. College of 
Medicine, Seoul, South Korea; 7Dept. of Psychiatry, School of Medicine, 
Gachon Univ., Incheon, South Korea; 8Dept. of Psychiatry, Inje Univ. 
College of Medicine, Ilsan, South Korea; 9Dept. of Biostatistics, Korea 
Univ. College of Medicine, Seoul, South Korea;10Dept. of Psychiatry, 
University of California, San Diego, CA, USA. 11Scripps Clinic Viterbi 
Family Sleep Center, La Jolla, USA † These individuals contributed 
equally to this article as co-first authors. *Corresponding author. 
Heon-Jeong Lee, MD, PhD, Department of Psychiatry, Korea University 
College of Medicine, 73 Inchon-ro, Seongbuk-gu, Seoul 136–705, 
Republic of Korea Tel: +82-2-920-6721, Fax: +82-2-929-7679, E-mail: 
leehjeong@korea.ac.kr
Abstract
Disturbances in circadian rhythms have been suggested as a 
possible cause of bipolar disorder (BD). However, mechanisms 
for circadian dysregulation of BD have not been clearly identi-
fied. We observed circadian rhythms from acute exacerbation to 
recovery states in hospitalized patients with BD, and compared 
them with rhythms of healthy control participants. Included 
in the study were 31 mood episodes of 26 BD patients, and 18 
healthy control measurements. Clinical symptoms were evalu-
ated at baseline, repeated 2 weeks intervals during hospitali-
zation and right before discharge. All participants wore wrist 
actigraphs during the studies. Sample collections of saliva and 
buccal cells were obtained at 8:00, 11:00, 15:00, 19:00, and 23:00 
for two consecutive days for healthy controls. From BP patients, 
sample collections were performed with the same schedule in 
baselines and repeated at 2 weeks intervals during hospitali-
zation and just before discharge. Molecular circadian rhythms 
had different phases during acute BD compared to phases in 
the recovered states. For manic episodes, there were three 
types classified according to their phases. In acute states, type 
1 phases were about 7 hours advanced, type 2 were about 17 
hours delayed, and type 3 were about 6~7 hours delayed. For 
depressive episodes, circadian rhythms phases were about 4~5 
hours delayed in acute states. After treatment, circadian phases 
resembled those of healthy controls. Circadian rhythm phase 
shifts might be a causal mechanism of BD, and we suggest that 
there are three types of circadian rhythm phase shift in mania.
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Abstract
Introduction: Oxytocin may play a role mood regulation (1). 
Recent evidence found serum oxytocin levels of bipolar I disor-
der (BP I) patients in manic episode were significantly higher 
than those of the BP I patients in depressive episode or remis-
sion status, and also healthy subjects (2). However, if the dif-
ference existed between major depressive disorder (MDD) and 
BP II is unclear. This study aimed to investigate the serum oxy-
tocin levels in drug-naïve MDD and BP II patients in their major 
depressive episodes before and after receiving pharmacological 
treatment.
Methods: 96 healthy controls (41 male, 55 female), 261 BP II and 
97 MDD patients were enrolled. Plasma oxytocin levels were 
measured.
Results: The serum oxytocin level of the BP II patients (42.0 ± 23.7) 
was significantly higher than those of the MDD patients 
(31.9 ± 18.4, p < .01) and controls (28.4 ± 14.0, p < 0.01). After treat-
ment, the serum oxytocin level of BP II increased significantly 
(p < 0.001). However, it remained unchanged in the MDD group.
Conclusion: The oxytocin level may be a biomarker of BP in 
either manic or depressive episodes. The increase of oxytocin 
levels might underlying a compensate process during the treat-
ment course in BP II patients.
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Abstract
Background: A  large body of data suggests that inflammation 
may play a role in the pathophysiology of mental disorders and 
that psychotropic drugs exhibit anti-inflammatory properties. 
The transcription factor nuclear factor kappa B (NF-κB) plays a 
pivotal role in the regulation of various inflammatory responses. 
Translocation of NF-κB proteins (e.g., p65) from the cytoplasm 
to the nucleus is associated with increased expression of pro-
inflammatory mediators such as prostaglandin (PG) E2 and 
tumor necrosis factor (TNF)-α.
Objectives: This study was undertaken to examine the effects of 
olanzapine and valproate on nuclear phospho-p65 (P-p65), PGE2 
and TNF-α levels in frontal cortex (FC) and hypothalamus (HT) of 
lipopolysaccharide (LPS)-treated rats.
Methods: Rats were treated with olanzapine (10 mg/kg) or val-
proate (100 mg/kg) for 28 days through a single daily intraperi-
tonteal (ip) injection. On day 29, at 2 hours post drug treatment, 
rats were injected (ip) with saline or LPS (1 mg/kg). At 1.5 
hour post LPS injection rats were sacrificed and FC and HT 
were excised. FC and HT were homogenized and centrifuged. 
Supernatants were separated for determination of PGE2 and 
TNF-α levels. Pellets were further processed for determination 
of nuclear P-p65. PGE2, P-p65 and TNF-α levels were measured 
by specific ELISA kits.
Results and Discussion: LPS significantly increased PGE2 but not 
TNF-α levels in HT. Olanzapine significantly decreased PGE2 
and TNF-α levels in HT whereas valproate had a non-signifi-
cant effect. LPS significantly increased TNF-α levels but did not 
alter PGE2 levels in FC. Mostly, olanzapine and valproate did 
not significantly alter PGE2 and TNF-α levels in FC. Moreover, 
LPS significantly elevated nuclear P-p65 levels in HT and FC. 
Olanzapine significantly decreased P-p65 levels in HT, while val-
proate caused a non-significant reduction. Both drugs did not 
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